P
Piramal Pharma
PPLPHARMA Share Price
Healthcare155.37
as on 10 Mar 2026 at 15:48
Market Cap
₹20,653 Cr
PE Ratio
-123.00
ROCE
7.02%
PPLPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
20,653
PE Ratio
-123.00
PB Ratio
2.49
Dividend Yield
0.09%
ROE
1.12%
ROCE
7.02%
Book Value (₹)
60.77
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 34.95% | 34.95% | 34.86% | 34.86% | 34.86% |
| Domestic Institutional Investors (DII) | 14.10% | 14.78% | 14.26% | 14.89% | 15.69% |
| Foreign Institutional Investors (FII) | 31.68% | 31.49% | 30.86% | 30.27% | 29.66% |
| Public Investors | 13.29% | 13.11% | 14.07% | 14.12% | 14.11% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
PPLPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
543635
NSE Scrip Name
PPLPHARMA
ISIN
INE0DK501011



